Pathfinder Cell Therapy, Inc.
PFND
Rank in Stocks
#34008
Pathfinder Cell Therapy, Inc. is an emerging biotechnology firm specializing in... Pathfinder Cell Therapy, Inc. is an emerging biotechnology firm specializing in regenerative medicine. This company is dedicated to pioneering innovative cell-based and associated treatments designed to address a range of illnesses and health issues, particularly those involving localized cellular injury within organs. Its proprietary technology shows promise for tackling conditions such as diabetes, kidney disease, heart attacks (myocardial infarction), and peripheral vascular ailments, among others. Established in 2008, the company maintains its corporate headquarters in Cambridge, Massachusetts.
Share Price
$0.0001
Last synced: 2026-11-10
Market Cap
$66.72K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Pathfinder Cell Therapy, Inc. (PFND)
Category
Healthcare
EPS for Pathfinder Cell Therapy, Inc. (PFND)
EPS as of September 2015 TTM: $0.00
According to Pathfinder Cell Therapy, Inc.'s latest financial reports, its current EPS (TTM) is $0.00. At the end of 2014 the company had an EPS of 0.00, equal to its 2013 EPS of 0.00.
EPS history for Pathfinder Cell Therapy, Inc. from 2000 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | 0.00 | -7.41% |
| 2014 | 0.00 | -7.41% |
| 2013 | 0.00 | -20.59% |
| 2012 | 0.00 | -90.56% |
| 2011 | $-0.04 | 700.00% |
| 2010 | 0.00 | -88.94% |
| 2009 | $-0.04 | -16.43% |
| 2008 | $-0.05 | -10.31% |
| 2007 | $-0.05 | 9.70% |
| 2006 | $-0.05 | 50.00% |
| 2005 | $-0.03 | 0.00% |
| 2004 | $-0.03 | -28.10% |
| 2003 | $-0.05 | -29.38% |
| 2002 | $-0.07 | 16.70% |
| 2001 | $-0.06 | 8.79% |
| 2000 | $-0.05 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $-0.99 | 47,042.86% |
US
|
|
| $15.66 | -745,814.29% |
US
|
|
| $-7.07 | 336,566.67% |
US
|
|
| $-5.29 | 251,804.76% |
AU
|
|
| $12.88 | -613,438.10% |
BE
|
Questions about Pathfinder Cell Therapy, Inc.'s earnings per share (EPS)
What is Pathfinder Cell Therapy, Inc.'s earnings per share (EPS)?
Pathfinder Cell Therapy, Inc.'s earnings per share (EPS) over the last twelve months is $0.00, as of Sep 2015.
What was Pathfinder Cell Therapy, Inc.'s earnings per share (EPS) in 2014?
In 2014, Pathfinder Cell Therapy, Inc.'s earnings per share (EPS) was 0.00, compared with 0.00 in 2013.
How has Pathfinder Cell Therapy, Inc.'s earnings per share (EPS) changed since 2009?
From 2009 to 2014, Pathfinder Cell Therapy, Inc.'s earnings per share (EPS) was highest in 2014 (0.00) and lowest in 2011 ($-0.04).
How does Pathfinder Cell Therapy, Inc.'s earnings per share (EPS) compare with similar companies?
Pathfinder Cell Therapy, Inc.'s earnings per share (EPS) ($0.00) is higher than that of 3 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with $15.66.